Table 3. Association between HER3/HER4 over-expression and overall survival (OS) in GC.
HER family members | OS | Number of studies | Number of patients | Heterogeneity | Model | OR(95%CI) | P value | |
---|---|---|---|---|---|---|---|---|
I2(%) | P value | |||||||
HER3 | 1-year OS | 5 | 789 | 0 | 0.78 | FE | 0.89(0.83,0.96) | 0.002 |
3-year OS | 4 | 687 | 25 | 0.26 | FE | 0.70(0.62,0.80) | <0.00001 | |
5-year OS | 3 | 566 | 44 | 0.17 | FE | 0.71(0.61,0.84) | <0.00001 | |
HER4 | 1-year OS | 3 | 566 | 28 | 0.25 | FE | 1.03(0.93,1.14) | 0.55 |
3-year OS | 3 | 566 | 9 | 0.33 | FE | 1.01(0.86,1.18) | 0.94 | |
5-year OS | 3 | 566 | 0 | 0.52 | FE | 1.09(0.91,1.30) | 0.37 |
Abbreviations: OS: overall survival; RR: risk ratio; CI: confidence interval; FE: fixed-effect model; RE: random-effect model